Last reviewed · How we verify
NCT03716609
Effects of Magnesium Supplementation on Hemodynamic Parameters and Cognitive Function
NA trial testing Magnesium Citrate in Cognitive Function in 50 participants. Completed in 30 June 2021.
30 June 2019
Quick facts
| Lead sponsor | Academia Sinica, Taiwan |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | sequential |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 50 |
| Start date | 23 October 2018 |
| Primary completion | 30 June 2019 |
| Estimated completion | 30 June 2021 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- Magnesium Citrate (MAGNESIUM CITRATE) — full drug profile →
- Food grade citrate acid
- Splenda(Sucralose)
Conditions studied
- Cognitive Function — all drugs for Cognitive Function →
Sponsor
Academia Sinica, Taiwan — full company profile →
Who can join
60 and older, any sex, with Cognitive Function. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Using a double-blind randomized controlled trial design, this study intends to evaluate the short-term effect of magnesium citrate on cognitive functions and hemodynamic parameters in MCI elders, including Montreal Cognitive Assessment, working memory test-digit span test, carotid artery flow velocity, ankle-brachial blood pressure ratio, and urinary magnesium.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03716609
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Magnesium Citrate
Trials testing the same drug.
- NCT05597150 — The Exploration of the Regulatory Effect of Magnesium on Intestinal Flora in Healthy Adults · NA · completed
- NCT04462796 — The Effect of Magnesium Citrate Supplementation in Restless Legs Syndrome (RLS) · NA · unknown
Other recruiting trials for Cognitive Function
Currently open trials in the same condition.
- NCT07586696 — Effects of Exercise Board Games on Cognitive Function in Older Adults · NA · active not recruiting
- NCT07245784 — Radicle Clarity™ RBB: A Study Assessing the Impact of Health and Wellness Products on Cognitive Function and Related Hea · NA · recruiting
- NCT07103343 — MOVI-OLE! [Open Learning Environments] · NA · active not recruiting
- NCT07312435 — B-vitamins and Omega-3 Fatty Acids and Biomarkers of Brain Atrophy. · NA · recruiting
- NCT07139210 — EFFECT OF PERCEPTUAL-MOTOR TRAINING ON COGNITIVE FUNCTIONS, MOTOR ABILITIES AND QUALITY OF LIFE IN CHILDREN WITH ATTENTI · NA · active not recruiting
Other Academia Sinica, Taiwan trials
Trials by the same sponsor.
- NCT06938763 — Evaluation of the Safety, Tolerability, and Pharmacokinetics of J4 in Healthy Adults · Phase 1 · recruiting
- NCT06223386 — Total Lifestyle Reconstruction for Body Weight Control and Maintenance · NA · active not recruiting
- NCT05278910 — Innovative Methods to Reduce Emissions and Health Impacts of Deep-frying · NA · unknown
- NCT05248763 — Taiwan Cancer Moonshot Project · recruiting
- NCT05201898 — Dietary Intervention for Cardiovascular Disease · NA · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03716609 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Academia Sinica, Taiwan
- Last refreshed: 26 January 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03716609.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing